Shares of Orthofix International NV (OFIX) surged 5.60% on November 7th, 2024, driven by a series of positive developments for the medical device maker.
Orthofix reported better-than-expected financial results for the third quarter of 2024. The company posted adjusted earnings per share of $0.07, surpassing analysts' estimates of a $0.15 loss. Revenue also beat expectations, rising 6.8% year-over-year to $196.61 million, exceeding the consensus estimate of $196.52 million.
In addition to the solid Q3 performance, Orthofix announced a new $275 million senior secured term loan credit agreement. This financing deal provides the company with additional capital to support its growth initiatives and operations.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。